Needham & Company LLC Reaffirms Buy Rating for Enovis (NYSE:ENOV)

Enovis (NYSE:ENOV – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a report released on Friday, Benzinga reports. They currently have a $70.00 price objective on the stock. Needham & Company LLC’s price objective indicates a potential upside of 17.65% from the stock’s previous close. […]

Related Keywords

Robertw Baird ,Phillip Benjamin Ben Berry ,Rajiv Vinnakota ,Ridgewood Investments ,Headlands Technologies ,Harbor Capital Advisors Inc ,Central Bank Trust Co ,Enovis Company Profile ,Wells Fargo Company ,Enovis Corporation ,Securities Exchange Commission ,Needham Company ,Get Free Report ,Wells Fargo ,Exchange Commission ,Director Rajiv Vinnakota ,Capital Advisors ,Enovis Daily ,Genovis ,Nyse Enov ,Senov ,Medical ,Reiterated Rating ,Needham Company Llc ,